Back to Rankings

RGNX

REGENXBIOA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
RGNX vs peer average
89/100
RGNX vs. peer average (A vs. C)
Grade spread
A 2 · B 1 · C 1 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

NVCT is the first available peer comparator.

Loose small-cap biotech comparison; useful mainly for assessing binary clinical and financing risk rather than shared indication or product economics.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerNVCTNuvectis
RGNX
REGENXBIO
NVCT
Nuvectis
Grade
A
D
Momentum
99
100
Value
41
41
Sentiment
62
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs NVCT

RGNX / NVCT
Grade Position
Above peers
RGNX vs. peer average (A vs. C)
89/100
Momentum
99
NVCT
Value
41
RGNX
Sentiment
62
RGNX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RGNX
1
NVCT
NVCT
D
40/100
+3
2
PRME
PRME
D
40/100
+3
3
MYGN
MYGN
A
100/100
Even
4
TLRY
Tilray Brands Inc Common
F
20/100
+4
5
DNA
Ginkgo Bioworks Holdings Inc Class A Common
F
20/100
+4
NVCT is the first peer returned for this comparison set.